We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Molecular Diagnostics

Image: IsoPSA is a blood-based test designed to aid in prostate biopsy decision‑making for men aged 50 years and older with elevated PSA levels (image credit: Shutterstock)

Blood Test Refines Biopsy Decisions in Prostate Cancer

A blood-based test gains ISO 13485 certification, enabling scaled use to refine prostate biopsy decisions. More...
13 May 2026
Image: Graphical Abstract (Jiaming Li, et al. Cell, 2026. doi:10.1016/j.cell.2026.04.025)

Digital Aging Twin Quantifies Biological Aging Across Multiple Organ Systems

A new AI system quantifies biological and organ-specific aging, predicting age within 3.9 years and enabling plasma proxy clocks. More...
13 May 2026
Image: Pleiotropic synapse-related genes expressed in peripheral leukocytes of patients with major depressive disorder. The figure summarizes molecular pathways shared between peripheral immune alterations and central synaptic processes in major depressive disorder (Adri, A.S., Nóbile, A.L., de Albuquerque, D.G. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-39284-y)

Blood Gene Signature Differentiates Major Depressive Disorder

Researchers identify an 18-gene blood signature that distinguishes major depression and highlights neuroimmune comorbidity links. More...
13 May 2026
Image: The schematic diagram links key MASLD, MASH, and MASLD-HCC molecular drivers to emerging multi‑omics biomarkers and therapeutic modalities, highlighting the current barriers in clinical translation and strategic solutions aimed at refined risk stratification and personalized medicine (Photo courtesy of ©Science China Press)

Emerging Biomarkers Advance Early Detection of MASLD and Liver Cancer Risk

Multi-omic panels combining genetic, metabolic, and microbiome markers have outperformed traditional MASH and fibrosis assessments.

More...
12 May 2026
Image: The patented method serves as the amplification engine within the company’s SeekIt platform, which integrates nucleic acid extraction, amplification, and detection in a portable system (Photo courtesy of Seek Labs)

Patented Isothermal Amplification Chemistry Advances Decentralized Testing

A new isothermal amplification chemistry delivers equipment-free, single-reaction nucleic acid detection at the point of care. More...
12 May 2026
Image: Unlike standard tests that detect bacteria directly, host-response assays measure the body\'s immune response, potentially enabling earlier infection detection and risk identification (image credit: Adobe Stock)

Finger-Prick Blood Test Aids Early Tuberculosis Detection and Risk Stratification

A new finger-prick host-response blood test detects active TB and estimates short-term progression risk in household contacts. More...
11 May 2026
Image: MyProstateScore2.0 – Active Surveillance Visual Abstract (Jeffrey J. Tosoian et al,  Journal of Urology (2026) DOI: 10.1097/ju.0000000000005095)

Urine Test Beats MRI in Identifying Prostate Cancer Upgrading During Active Surveillance

A new urine test outperforms PSA and MRI to detect higher-grade disease during active surveillance, cutting biopsies by up to 64%. More...
11 May 2026
Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Immunofluorescence Analyzer
IFA System


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.